Company Overview of Neurim Pharmaceuticals (1991) Ltd.
Neurim Pharmaceuticals (1991) Ltd. operates as a drug discovery and development company. It focuses on age-related disorders in the central nervous system. The company provides Circadin, a prolonged release melatonin for insomnia. Its products include orlogin, for circadian rhythm disorders; Neu-120, which has been developed as adjunct therapy to levodopa in patients with motor fluctuations; Neu-P11, a melatonin agonist binds with high affinity to melatonin receptors; and Neu-105 for the treatment of asthma. The company was founded in 1991 and is based in Tel-Aviv, Israel.
8 Hanechoshet St.
Founded in 1991
972 3 768 4911
972 3 649 4568
Key Executives for Neurim Pharmaceuticals (1991) Ltd.
Neurim Pharmaceuticals (1991) Ltd. Key Developments
Similar Private Companies By Industry
|Abital Pharma Pipelines Ltd.||Middle East/Africa|
|Active PX Ltd.||Middle East/Africa|
|Advanced Inhalation Technology Ltd.||Middle East/Africa|
|Advanced Inhalation Therapies (AIT) Ltd.||Middle East/Africa|
|Angio B Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Neurim Pharmaceuticals (1991) Ltd., please visit www.neurim.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.